NCT01203878 - Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Actinic Keratosis

Interventions

DRUG

Photodynamic therapy

Administered 4 weeks after completion of imiquimod therapy

DRUG

Imiquimod

Imiquimod 3.75% cream, up to 2 packets, applied topically daily for two 2-week cycles separated by a no-treatment interval of 2-weeks, followed observation

Trial Locations (3)

28207

Dermatology, Laser & Vein Specialists of the Carolinas, Charlotte

37215

Tennessee Clinical Research Center, Nashville

80113

AboutSkin Dermatology and DermSurgery, PC, Englewood